RELORN
Dead / Abandoned — Abandoned — after publication (as of 21 Jun 2023)
What this means for you
This application is over — abandoned 20 Jun 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88811401
- Mark type
- Stylized text
- Filed
- 26 Feb 2020
- Published for opposition
- 30 Jun 2020
- Abandoned
- 20 Jun 2023
- Attorney of record
- Eric Stenshoel
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for pain relief and fever reduction
Owner
- Unipharm, Inc., New York, NY, US
- Unipharm, Inc., New York, NY, US
Prosecution history
- 21 Jun 2023 — ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
- 21 Jun 2023 — ABANDONMENT - AFTER PUBLICATION
- 20 Jun 2023 — TEAS EXPRESS ABANDONMENT RECEIVED
- 28 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Feb 2023 — SOU EXTENSION 5 GRANTED
- 08 Feb 2023 — SOU EXTENSION 5 FILED
- 27 Feb 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 25 Aug 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Aug 2022 — SOU EXTENSION 4 GRANTED
- 23 Aug 2022 — SOU EXTENSION 4 FILED
- 23 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 19 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Feb 2022 — SOU EXTENSION 3 GRANTED
- 17 Feb 2022 — SOU EXTENSION 3 FILED